ProfoundBio
Business Services · Washington, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
401 Terry Ave N, Seattle, Washington, 98...Phone Number
+86 51267991868Website
www.profoundbio.comRevenue
$14 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About ProfoundBio
ProfoundBio is a clinical stage biotherapeutics company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer. Built on innovative technology platforms, ProfoundBio has developed a pipeline consisting of multiple candidates that are currently in discovery, preclinical development, and clinical stage targeting a broad range of tumors.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ProfoundBio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if ProfoundBio had a recent Job posting/layoffs
ProfoundBio, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once ProfoundBio has new funding data
Earning: See what the market has to say on ProfoundBio recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at ProfoundBio
Check if ProfoundBio has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when ProfoundBio launches new products
Check out if ProfoundBio is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined ProfoundBio as Masked Content
Find 2 more new buyers
Compare Similar Companies to ProfoundBio
Compare insights from companies similar to ProfoundBio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
ProfoundBio
$14M
51-200
Private
$247M
2019
N/A
ProfoundBio financials insights
Gather financial insights about ProfoundBio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Other Financing Round
$10M
2022
Series A
$125M
2024
Series B
$112M
ProfoundBio Tech Stack
Most Recent Scoops
Mergers & Acquisitions (M&A)
Mergers & Acquisitions
Funding
Event
Events
Event
Events
New Hire
Executive Move
ProfoundBio News & Media
ProfoundBio Discovers The Joys Of Having A Wealthy Owner
Summary Cancer treatment maker ProfoundBio announced it will be purchased by Denmark’s Genmab for $1.8 billion. The deal is the... Read More The post ProfoundBio Discovers The Joys Of Having A Wealthy Owner appeared first on citybiz.ProfoundBio to Present Data on Multiple Preclinical Programs From Its Antibody-Drug Conjugate Pipeline at the American Association for Cancer Research Annual Meeting 2024
SEATTLE, April 4, 2024 /PRNewswire/ -- ProfoundBio, a clinical-stage biotechnology company dedicated to developing novel antibody-drug conjugate (ADC) therapies for patients with cancer, today announced its participation at the upcoming American Association for Cancer Research (AACR)...Genmab Leans into Hot ADC Space with $1.8B ProfoundBio Acquisition - BioSpace
Genmab announced Wednesday it is buying ProfoundBio and its pipeline of next-generation antibody-drug conjugates being developed for gynecologic cancers and other solid tumors.Biotech giant Genmab to acquire Seattle company ProfoundBio in $1.8B deal
ProfoundBio, a Seattle-based biotech firm developing drugs to treat ovarian and endometrial cancers, will be acquired by publicly traded Danish drugmaker Genmab in a $1.8 billion all-cash deal expected to close in the first half of this year, the companies announced Wednesday.
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding ProfoundBio
Sign Up For FreeTo access detailed company insights
ProfoundBio is a clinical stage biotherapeutics company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer. Built on innovative technology platforms, ProfoundBio has developed a pipeline consisting of multiple candidates that are currently in discovery, preclinical development, and clini... Read More
